Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 5

Inflammation as a potential mediator for the association between periodontal disease and Alzheimer’s disease

Authors Amber Watts, Eileen M Crimmins, Margaret Gatz

Published 10 October 2008 Volume 2008:4(5) Pages 865—876


Review by Single-blind

Peer reviewer comments 2

Amber Watts1, Eileen M Crimmins1, Margaret Gatz2

1Davis School of Gerontology; 2Department of Psychology, University of Southern California, Los Angeles, CA, USA

Abstract: Periodontal disease (PDD) is associated with increased risk of cardiovascular disease, cerebrovascular disease, and mortality in many studies, while other studies have begun to suggest an association of PDD with Alzheimer’s disease (AD). This paper discusses how infectious pathogens and systemic infection may play a role in AD. The roles of infection and inflammation are addressed specifically with regard to known AD pathologic lesions including senile plaques, neuron death, neurofibrillary tangles, and cerebrovascular changes. A testable model of proposed pathways between periodontal infection and AD is presented including three possible mechanisms: a) direct effects of infectious pathogens, b) inflammatory response to pathogens, and c) the effects on vascular integrity. The role of gene polymorphisms is discussed, including apolipoprotein (APOE) ε4 as a pro-inflammatory and pro-infection genotype.

Keywords: periodontal disease, infection, inflammation, Alzheimer’s disease

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Siliceous mesostructured cellular foams/ poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) composite biomaterials for bone regeneration

Yang S, Xu S, Zhou P, Wang J, Tan H, Liu Y, Tang TT, Liu CS

International Journal of Nanomedicine 2014, 9:4795-4807

Published Date: 20 October 2014

Cationic star-shaped polymer as an siRNA carrier for reducing MMP-9 expression in skin fibroblast cells and promoting wound healing in diabetic rats

Li N, Luo HC, Yang C, Deng JJ, Ren M, Xie XY, Lin DZ, Yan L, Zhang LM

International Journal of Nanomedicine 2014, 9:3377-3387

Published Date: 15 July 2014

Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system

Ribeiro TG, Chávez-Fumagalli MA, Valadares DG, Franca JR, Rodrigues LB, Duarte MC, Lage PS, Andrade PHR, Lage DP, Arruda LV, Abánades DR, Costa LE, Martins VT, Tavares CAP, Castilho RO, Coelho EAF, Faraco AAG

International Journal of Nanomedicine 2014, 9:877-890

Published Date: 14 February 2014

Aggressive retinal astrocytoma associated with tuberous sclerosis

Tomida M, Mitamura Y, Katome T, Eguchi H, Naito T, Harada T

Clinical Ophthalmology 2012, 6:715-720

Published Date: 9 May 2012

Long-term outcomes of a pseudo 360-degree trabeculotomy ab externo technique for congenital glaucoma at children's medical center

Saltzmann RM, Reinecke S, Lin X, Cavanagh HD, Whitson JT

Clinical Ophthalmology 2012, 6:689-698

Published Date: 9 May 2012

Traumatic brain injury: future assessment tools and treatment prospects

Steven R Flanagan, Joshua B Cantor, Teresa A Ashman

Neuropsychiatric Disease and Treatment 2008, 4:877-892

Published Date: 10 October 2008

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats

Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, Stylianos Tsakiris

Neuropsychiatric Disease and Treatment 2008, 4:687-699

Published Date: 8 August 2008

Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial

Mauro Campos, Mariana Ávila, Anelise Wallau, Cristina Muccioli, Ana Luisa Höfling-Lima, Rubens Belfort Jr

Clinical Ophthalmology 2008, 2:331-338

Published Date: 6 June 2008